A $11 Billion ETF Quietly Outperforms the Total Market by Favoring Profitable Stocks

Photo of Austin Smith
By Austin Smith Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
A $11 Billion ETF Quietly Outperforms the Total Market by Favoring Profitable Stocks

© Andrew Angelov / Shutterstock.com

Most broad U.S. equity ETFs hand the biggest positions to the biggest companies, regardless of whether those companies are cheap or profitable. Avantis U.S. Equity ETF (NYSEARCA:AVUS) takes a different approach: it tilts the portfolio toward stocks that score well on both value and profitability, the two factors academic research most consistently links to long-run outperformance. That distinction is subtle on the surface but meaningful over a full market cycle.

What AVUS Is Designed to Do

AVUS occupies a middle ground sometimes called “systematic active” or enhanced indexing. Avantis, a subsidiary of American Century, screens the broad U.S. market and overweights companies trading at lower valuations relative to their fundamentals while emphasizing firms with strong current profitability. The result is a diversified, 500+ holding portfolio that resembles the total market but with deliberate factor tilts built in.

The return engine here is factor exposure, not market-cap momentum. By systematically favoring profitable, reasonably priced companies, AVUS aims to capture a return premium over a pure cap-weighted index across long time horizons. At 0.15% in annual expenses and just 1% portfolio turnover, the strategy is designed to be tax-efficient and low-cost, which matters when compounding over decades.

Does It Deliver?

AVUS has meaningfully outpaced its benchmark over both short and long horizons. Over the past year, AVUS returned 19.88% compared to 15.22% for Vanguard Total Stock Market ETF (NYSEARCA:VTI) — a gap driven largely by the value and profitability tilts paying off as rate-sensitive investors rotated toward cheaper, cash-generative businesses. That outperformance is not a one-year anomaly. Over five years, AVUS has compounded at 87.59% versus 68.86% for VTI, suggesting the factor premium has been durable rather than episodic and that the strategy’s tilt toward profitable, reasonably priced companies has added consistent value across different market environments.

The $11.1 billion in AUM reflects broad institutional and retail confidence in the strategy, though factor tilts can lag for extended stretches before delivering.

The Tradeoffs

AVUS still carries meaningful tech concentration. The top five holdings represent roughly 20.4% of the portfolio, and Information Technology is the largest sector at 22.6%. Investors expecting a deep value tilt away from mega-cap tech will find AVUS less aggressive than pure value ETFs. The factor premium is also not guaranteed in any given period — value and profitability tilts underperformed significantly during the 2017–2020 growth dominance era, requiring multi-decade patience.

On the income side, the fund’s 1.04% dividend yield is modest relative to the 10-year Treasury’s 4.03%, making AVUS a pure total-return vehicle rather than a defensive or income-generating one.

Contact [email protected] for any questions or corrections.

Photo of Austin Smith
About the Author Austin Smith →

Austin Smith is a financial publisher with over two decades of experience as an investor, analyst, and advisor. He covers stocks, ETFs, Artificial intelligence and personal finance for 24/7 Wall St. Previously, he spent over a decade at The Motley Fool as a senior editor for Fool.com, portfolio advisor for Millionacres, and launched The Ascent to help reader take control of their personal finances.

His work has been featured on Fool.com, NPR, CNBC, USA Today, Yahoo Finance, MSN, AOL, Marketwatch, and many other publications. He is as an advisor to private companies, and co-hosts The AI Investor Podcast with Eric Bleeker. 

When not looking for investment opportunities, he can be found skiing, running, or playing soccer with his children. Learn more about Austin's investment approach here.

Continue Reading

Top Gaining Stocks

META Vol: 40,760,422
KMX Vol: 2,288,021
WY Vol: 6,523,553
SBAC Vol: 1,443,801
NVDA Vol: 148,249,982

Top Losing Stocks

MRNA Vol: 9,176,778
CTRA Vol: 73,319,495
CRWD Vol: 9,269,567
DDOG Vol: 5,135,556
EPAM Vol: 1,164,561